A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Triple Cross-Over Study Investigating The Safety, Oral Steady-State Pharmacokinetics, And Clinical Activity Of 20 Mg Omnitram And 50 Mg Tramadol In Normal Human Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2015
At a glance
- Drugs O-desmethyltramadol (Primary) ; Tramadol
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Syntrix Biosystems
- 22 Oct 2014 Last checked against ClinicalTrials.gov record.
- 14 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Aug 2014 New trial record